Pharmaceutical giant Pfizer (NYSE: PFE) was a big winner during the COVID-19 pandemic. Its vaccine and antiviral pill generated billions of dollars in sales. However, that revenue source has ...

Pfizer has a very low valuation and a sky-high dividend yield. But this could be a broken stock, not so much a broken company. Pfizer's product sales could churn as patents expire, but the stock ...

In a report released today, Akash Tewari from Jefferies maintained a Buy rating on Pfizer (PFE – Research Report), with a price target of $34.00. The company’s shares closed yesterday at $22.63.

The authors explore the shifting and opaque landscape facing companies that are required to maintain policies addressing the handling of and trading on material, non-public information.

OpenAI has significantly leveled up the image generating capabilities of ChatGPT, as part of an update to the GPT-4o model introduced last May. The new and improved AI image generator is out now ...

BALTIMORE (WBFF) — Celebrating their "29th birthday," the Baltimore Ravens have unveiled a commemorative logo and announced a series of fan engagements to mark the beginning of their 30th NFL ...

The Ravens team name was voted for and revealed on March 29, 1996. To honor that milestone, the team released a special logo and announced that that "limited-edition merchandise and special ...

Finally, on the lighting tab, you can choose how bright you want the illuminated Razer logo on the front, as well as the RGB keyboard, on both battery and while charging. This is also where you ...

From 2021 through 2024, Pfizer paid more than $12.8 billion in U.S. income taxes, as publicly reported in the company’s financials and securities filings, the spokesperson added.

Pfizer is under federal investigation over whether it delayed announcing its COVID-19 vaccine success in 2020 for political reasons. The probe follows a tip from a former Pfizer scientist, now at GSK, ...

Federal prosecutors in Manhattan are probing a claim by GSK that Pfizer delayed announcing its Covid shot's success in 2020 until after that year's election, the Wall Street Journal reported, citing ...